<p>瑞银资产管理（UBS AM）是瑞银资产管理美洲有限公司（UBS ASSET MANAGEMENT AMERICAS LLC）的一家独立业务单位，根据其最近向证券交易委员会（SEC）披露的信息，在第四季度将其在丹纳赫公司（Danaher Co.，NYSE:DHR - 免费报告）的持股增加了 11.4%。该机构投资者在此期间购买了 579,046 股后，持有 5,677,032 股该综合企业的股票。瑞银资产管理在最近的报告期末持有丹纳赫 0.79% 的股份，价值约为 13,031,630,000 美元。</p>
<ul>
<li>3 只提供强大价值和稳定性的股票</li>
</ul>
<p>其他几家大型投资者也调整了对该公司的持股。挪威银行在第四季度购买了价值约 21,307,400,000 美元的丹纳赫新头寸。雷蒙德·詹姆斯金融公司（Raymond James Financial Inc.）在第四季度收购了价值约 391,172,000 美元的丹纳赫股票新头寸。Two Sigma Advisers LP 在第四季度将其在丹纳赫的持股增加了 4,248.8%。Two Sigma Advisers LP 现在持有 1,639,500 股该综合企业的股票，价值 376,347,000 美元，此前在此期间又购买了 1,601,800 股。资本世界投资者（Capital World Investors）在第四季度将其在丹纳赫的持股增加了 32.7%。资本世界投资者现在持有 6,361,183 股该综合企业的股票，价值 1,460,215,000 美元，此前又购买了 1,566,658 股。最后，Point72 资产管理公司（Point72 Asset Management L.P.）在第四季度将其在丹纳赫的持股增加了 460.6%。Point72 资产管理公司现在持有 1,348,544 股该综合企业的股票，价值 309,558,000 美元，此前在上个季度又购买了 1,107,998 股。目前 79.05% 的股票由机构投资者和对冲基金持有。</p>
<h2>丹纳赫价格表现</h2>
<p>丹纳赫（DHR）周二开盘价为 196.33 美元。该公司的债务与股本比率为 0.31，流动比率为 1.40，速动比率为 1.05。该股票的市值为 1,405.1 亿美元，市盈率为 37.18，市盈增长比率为 2.66，贝塔值为 0.80。该公司的 50 日简单移动平均线为 196.69 美元，200 日简单移动平均线为 216.91 美元。丹纳赫公司的一年最低价为 171.00 美元，一年最高价为 281.70 美元。</p>
<ul>
<li>安捷伦科技因 “永恒化学品” 打击而蓬勃发展</li>
</ul>
<p>丹纳赫（NYSE:DHR - 获取免费报告）最近于 4 月 22 日（星期二）发布了其财报。该综合企业报告季度每股收益（EPS）为 1.88 美元，超出市场共识预期的 1.62 美元，超出幅度为 0.26 美元。丹纳赫的股本回报率为 10.82%，净利润率为 16.33%。该公司在本季度的收入为 57.4 亿美元，而分析师预期为 55.8 亿美元。卖方分析师预计丹纳赫公司在当前财年将发布每股收益 7.63 美元。</p>
<h2>丹纳赫宣布分红</h2>
<p>该公司最近还宣布了一项季度分红，将于 7 月 25 日（星期五）支付。6 月 27 日（星期五）登记在册的股东将获得每股 0.32 美元的分红。这相当于年化分红 1.28 美元，分红收益率为 0.65%。丹纳赫的分红支付比率为 24.85%。</p>
<h2>内部买卖</h2>
<ul>
<li>丹纳赫股票在 2024 年会创下新高吗？</li>
</ul>
<p>在其他消息中，董事长史蒂文·M·雷尔斯（Steven M. Rales）在 5 月 12 日（星期一）出售了 1,250,000 股该公司的股票，交易价格为 196.74 美元，总交易额为 245,925,000.00 美元。交易完成后，董事长现在直接持有 3,105,808 股公司股票，价值约 611,036,665.92 美元。此次交易使其持股减少了 28.70%。该交易已在证券交易委员会的备案中披露，相关信息可通过此链接查看。此外，执行副总裁克里斯托弗·保罗·赖利（Christopher Paul Riley）在 4 月 30 日（星期三）出售了 15,805 股该股票，交易价格为 198.00 美元，总交易额为 3,129,390.00 美元。交易完成后，该执行副总裁现在持有 15,179 股公司股票，价值 3,005,442 美元。这代表其持股减少了 51.01%。该交易的披露信息可在此处找到。目前 11.10% 的股票由内部人士持有。</p>
<h2>分析师设定新目标价</h2>
<p>DHR 已成为多份研究分析师报告的主题。花旗集团在 4 月 7 日（星期一）的研究报告中重申了对丹纳赫股票的 “买入” 评级。加拿大皇家银行在 4 月 23 日（星期三）的研究报告中重申了 “跑赢大盘” 评级，并对丹纳赫股票设定了 250.00 美元的目标价。摩根大通将丹纳赫股票的目标价从 280.00 美元下调至 260.00 美元，并在 4 月 22 日（星期二）的报告中对该股票设定了 “增持” 评级。瑞银集团在 4 月 23 日（星期三）的报告中将丹纳赫的目标价从 275.00 美元下调至 240.00 美元，并对该公司设定了 “买入” 评级。最后，StockNews.com 在 5 月 12 日（星期一）的研究报告中将丹纳赫的评级从 “持有” 上调至 “买入”。四位股票研究分析师对该股票给予了 “持有” 评级，十七位分析师给予了该公司股票 “买入” 评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “适度买入”，共识目标价为 264.40 美元。</p>
<p><strong>阅读我们最新的 DHR 股票分析</strong></p>
<h2>丹纳赫公司简介</h2>
<p>（免费报告）</p>
<p>丹纳赫公司设计、制造和销售专业、医疗、工业和商业产品及服务，业务遍及全球。生物技术部门提供生物处理技术、耗材和服务，推动、加速和整合治疗药物的开发和生产；细胞系和细胞培养基开发服务；用于生产的细胞培养基、工艺液体和缓冲液；色谱树脂、过滤技术、无菌灌装；一次性硬件和耗材及服务，如完整制造套件的设计和安装；实验室过滤、分离和纯化；实验室规模的蛋白质纯化和分析工具；试剂、膜和服务；以及医疗过滤解决方案。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票比丹纳赫更好</li>
<li>5 只值得考虑的高评级分红股票</li>
<li>这是 Roku 股票的看涨理由，潜在上涨幅度达两位数</li>
<li>经济报告在成功投资策略中的作用</li>
<li>Spotify 股票的反弹仍有上涨空间</li>
<li>为什么这些公司被认为是蓝筹股？</li>
<li>UnitedHealth 内部人士加码：UNH 股票是价值投资吗？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在丹纳赫吗？</h2>
<p>在你考虑丹纳赫之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而丹纳赫并不在名单上。</p>
<p>虽然丹纳赫目前在分析师中获得中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

丹纳赫

<p>瑞银资产管理（UBS AM），瑞银资产管理美洲有限责任公司的一个部门，在第四季度将其在丹纳赫公司（NYSE:DHR）的持股增加了 11.4%，目前持有 5,677,032 股，价值约为 13 亿美元。包括挪威银行和瑞蒙德·詹姆斯在内的其他投资者也增加了他们的持股。丹纳赫报告了强劲的收益，第一季度每股收益为 1.88 美元，超出预期。该公司宣布每股季度分红为 0.32 美元，收益率为 0.65%。内部人士出售股票的情况被注意到，董事长史蒂文·M·雷尔斯出售了 125 万股。分析师对丹纳赫保持积极评级</p>

<p>UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Danaher Co. (NYSE:DHR - Free Report) by 11.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,677,032 shares of the conglomerate's stock after purchasing an additional 579,046 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.79% of Danaher worth $1,303,163,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>瑞银资产管理（UBS AM）是瑞银资产管理美洲有限公司（UBS ASSET MANAGEMENT AMERICAS LLC）的一家独立业务单位，根据其最近向证券交易委员会（SEC）披露的信息，在第四季度将其在丹纳赫公司（Danaher Co.，NYSE:DHR - 免费报告）的持股增加了 11.4%。该机构投资者在此期间购买了 579,046 股后，持有 5,677,032 股该综合企业的股票。瑞银资产管理在最近的报告期末持有丹纳赫 0.79% 的股份，价值约为 13,031,630,000 美元。</p>
</div><ul>
<li>3 Stocks Offering Strong Value and Stability</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只提供强大价值和稳定性的股票</li>
</ul>
</div><p>Several other large investors have also modified their holdings of the business. Norges Bank purchased a new position in Danaher during the fourth quarter worth about $2,130,740,000. Raymond James Financial Inc. acquired a new position in shares of Danaher during the 4th quarter valued at about $391,172,000. Two Sigma Advisers LP lifted its holdings in shares of Danaher by 4,248.8% during the 4th quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate's stock worth $376,347,000 after acquiring an additional 1,601,800 shares during the period. Capital World Investors grew its holdings in Danaher by 32.7% in the fourth quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate's stock valued at $1,460,215,000 after purchasing an additional 1,566,658 shares during the period. Finally, Point72 Asset Management L.P. increased its position in Danaher by 460.6% during the fourth quarter. Point72 Asset Management L.P. now owns 1,348,544 shares of the conglomerate's stock worth $309,558,000 after purchasing an additional 1,107,998 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他几家大型投资者也调整了对该公司的持股。挪威银行在第四季度购买了价值约 21,307,400,000 美元的丹纳赫新头寸。雷蒙德·詹姆斯金融公司（Raymond James Financial Inc.）在第四季度收购了价值约 391,172,000 美元的丹纳赫股票新头寸。Two Sigma Advisers LP 在第四季度将其在丹纳赫的持股增加了 4,248.8%。Two Sigma Advisers LP 现在持有 1,639,500 股该综合企业的股票，价值 376,347,000 美元，此前在此期间又购买了 1,601,800 股。资本世界投资者（Capital World Investors）在第四季度将其在丹纳赫的持股增加了 32.7%。资本世界投资者现在持有 6,361,183 股该综合企业的股票，价值 1,460,215,000 美元，此前又购买了 1,566,658 股。最后，Point72 资产管理公司（Point72 Asset Management L.P.）在第四季度将其在丹纳赫的持股增加了 460.6%。Point72 资产管理公司现在持有 1,348,544 股该综合企业的股票，价值 309,558,000 美元，此前在上个季度又购买了 1,107,998 股。目前 79.05% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Danaher Price Performance</h2>
<div class="lb-trans"><h2>丹纳赫价格表现</h2>
</div><p>DHR opened at $196.33 on Tuesday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The stock has a market capitalization of $140.51 billion, a P/E ratio of 37.18, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80. The company's 50 day simple moving average is $196.69 and its 200-day simple moving average is $216.91. Danaher Co. has a one year low of $171.00 and a one year high of $281.70.</p>
<div class="lb-trans"><p>丹纳赫（DHR）周二开盘价为 196.33 美元。该公司的债务与股本比率为 0.31，流动比率为 1.40，速动比率为 1.05。该股票的市值为 1,405.1 亿美元，市盈率为 37.18，市盈增长比率为 2.66，贝塔值为 0.80。该公司的 50 日简单移动平均线为 196.69 美元，200 日简单移动平均线为 216.91 美元。丹纳赫公司的一年最低价为 171.00 美元，一年最高价为 281.70 美元。</p>
</div><ul>
<li>Agilent Technologies Thrives From the Forever Chemicals Crackdown</li>
</ul>
<div class="lb-trans"><ul>
<li>安捷伦科技因 “永恒化学品” 打击而蓬勃发展</li>
</ul>
</div><p>Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The company had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. Sell-side analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>丹纳赫（NYSE:DHR - 获取免费报告）最近于 4 月 22 日（星期二）发布了其财报。该综合企业报告季度每股收益（EPS）为 1.88 美元，超出市场共识预期的 1.62 美元，超出幅度为 0.26 美元。丹纳赫的股本回报率为 10.82%，净利润率为 16.33%。该公司在本季度的收入为 57.4 亿美元，而分析师预期为 55.8 亿美元。卖方分析师预计丹纳赫公司在当前财年将发布每股收益 7.63 美元。</p>
</div><h2>Danaher Announces Dividend</h2>
<div class="lb-trans"><h2>丹纳赫宣布分红</h2>
</div><p>The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.65%. Danaher's dividend payout ratio is 24.85%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，将于 7 月 25 日（星期五）支付。6 月 27 日（星期五）登记在册的股东将获得每股 0.32 美元的分红。这相当于年化分红 1.28 美元，分红收益率为 0.65%。丹纳赫的分红支付比率为 24.85%。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部买卖</h2>
</div><ul>
<li>Will Danaher stock hit new highs in 2024?</li>
</ul>
<div class="lb-trans"><ul>
<li>丹纳赫股票在 2024 年会创下新高吗？</li>
</ul>
</div><p>In other news, Chairman Steven M. Rales sold 1,250,000 shares of the business's stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the transaction, the chairman now directly owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. The trade was a 28.70% decrease in their position. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is available through this hyperlink. Also, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the sale, the executive vice president now owns 15,179 shares in the company, valued at $3,005,442. This represents a 51.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by insiders.</p>
<div class="lb-trans"><p>在其他消息中，董事长史蒂文·M·雷尔斯（Steven M. Rales）在 5 月 12 日（星期一）出售了 1,250,000 股该公司的股票，交易价格为 196.74 美元，总交易额为 245,925,000.00 美元。交易完成后，董事长现在直接持有 3,105,808 股公司股票，价值约 611,036,665.92 美元。此次交易使其持股减少了 28.70%。该交易已在证券交易委员会的备案中披露，相关信息可通过此链接查看。此外，执行副总裁克里斯托弗·保罗·赖利（Christopher Paul Riley）在 4 月 30 日（星期三）出售了 15,805 股该股票，交易价格为 198.00 美元，总交易额为 3,129,390.00 美元。交易完成后，该执行副总裁现在持有 15,179 股公司股票，价值 3,005,442 美元。这代表其持股减少了 51.01%。该交易的披露信息可在此处找到。目前 11.10% 的股票由内部人士持有。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>DHR has been the subject of a number of research analyst reports. Citigroup reissued a &#34;buy&#34; rating on shares of Danaher in a research report on Monday, April 7th. Royal Bank of Canada reissued an &#34;outperform&#34; rating and issued a $250.00 target price on shares of Danaher in a research note on Wednesday, April 23rd. JPMorgan Chase &amp; Co. reduced their target price on shares of Danaher from $280.00 to $260.00 and set an &#34;overweight&#34; rating on the stock in a report on Tuesday, April 22nd. UBS Group lowered their price target on Danaher from $275.00 to $240.00 and set a &#34;buy&#34; rating for the company in a report on Wednesday, April 23rd. Finally, StockNews.com upgraded Danaher from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note on Monday, May 12th. Four equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $264.40.</p>
<div class="lb-trans"><p>DHR 已成为多份研究分析师报告的主题。花旗集团在 4 月 7 日（星期一）的研究报告中重申了对丹纳赫股票的 “买入” 评级。加拿大皇家银行在 4 月 23 日（星期三）的研究报告中重申了 “跑赢大盘” 评级，并对丹纳赫股票设定了 250.00 美元的目标价。摩根大通将丹纳赫股票的目标价从 280.00 美元下调至 260.00 美元，并在 4 月 22 日（星期二）的报告中对该股票设定了 “增持” 评级。瑞银集团在 4 月 23 日（星期三）的报告中将丹纳赫的目标价从 275.00 美元下调至 240.00 美元，并对该公司设定了 “买入” 评级。最后，StockNews.com 在 5 月 12 日（星期一）的研究报告中将丹纳赫的评级从 “持有” 上调至 “买入”。四位股票研究分析师对该股票给予了 “持有” 评级，十七位分析师给予了该公司股票 “买入” 评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “适度买入”，共识目标价为 264.40 美元。</p>
</div><p><strong>Read Our Latest Stock Analysis on DHR</strong></p>
<div class="lb-trans"><p><strong>阅读我们最新的 DHR 股票分析</strong></p>
</div><h2>Danaher Company Profile</h2>
<div class="lb-trans"><h2>丹纳赫公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.</p>
<div class="lb-trans"><p>丹纳赫公司设计、制造和销售专业、医疗、工业和商业产品及服务，业务遍及全球。生物技术部门提供生物处理技术、耗材和服务，推动、加速和整合治疗药物的开发和生产；细胞系和细胞培养基开发服务；用于生产的细胞培养基、工艺液体和缓冲液；色谱树脂、过滤技术、无菌灌装；一次性硬件和耗材及服务，如完整制造套件的设计和安装；实验室过滤、分离和纯化；实验室规模的蛋白质纯化和分析工具；试剂、膜和服务；以及医疗过滤解决方案。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Danaher</li>
<li>5 Top Rated Dividend Stocks to Consider</li>
<li>Here's The Bull Case For Roku Stock With Double-Digit Upside</li>
<li>The Role Economic Reports Play in a Successful Investment Strategy</li>
<li>Spotify Stock's Rally Still Has Legs To Run Higher</li>
<li>Why Are These Companies Considered Blue Chips?</li>
<li>UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比丹纳赫更好</li>
<li>5 只值得考虑的高评级分红股票</li>
<li>这是 Roku 股票的看涨理由，潜在上涨幅度达两位数</li>
<li>经济报告在成功投资策略中的作用</li>
<li>Spotify 股票的反弹仍有上涨空间</li>
<li>为什么这些公司被认为是蓝筹股？</li>
<li>UnitedHealth 内部人士加码：UNH 股票是价值投资吗？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=DHR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Danaher Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在丹纳赫吗？</h2>
</div><p>Before you consider Danaher, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑丹纳赫之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而丹纳赫并不在名单上。</p>
</div><p>While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然丹纳赫目前在分析师中获得中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

丹纳赫公司（NYSE:DHR）的股票被瑞银资产管理美洲有限责任公司旗下的独立业务部门 UBS AM 购入